project id: TCGA-GBM; case submitter id: TCGA-28-5211; no matched normal low pass wgs: false; no matched normal targeted sequencing: false; no matched normal wgs: false; no matched normal wxs: false; selected normal low pass wgs: false; selected normal targeted sequencing: false; selected normal wgs: false; selected normal wxs: false; state: released; normal tumor genotype snp match: Yes; spectrophotometer method: UV Spec; age at index: 42; days to birth: -15507; ethnicity: not reported; gender: male; race: black or african american; vital status: Alive; year of birth: 1968; age at diagnosis: 15507; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 358.0; icd 10 code: C71.9; last known disease status: not reported; morphology: 9440/3; primary diagnosis: Glioblastoma; prior malignancy: not reported; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Brain, NOS; synchronous malignancy: Not Reported; tissue or organ of origin: Brain, NOS; tumor grade: Not Reported; year of diagnosis: 2010; treatment or therapy: yes; alcohol history: Not Reported; is ffpe: false; weight: 30.0; composition: Not Reported; intermediate dimension: 0.3; longest dimension: 1.0; preservation method: Unknown; shortest dimension: 0.2; sample id: 73f42a0f-e2a4-4f33-a1dd-689dd81986ad; sample submitter id: TCGA-28-5211-01C; portion id: 86054b11-2e23-44f0-a4b7-5119b52faad2; portion submitter id: TCGA-28-5211-01C-11; slide id: b1ea7af4-d703-4010-9cac-2f6f5aea70fe; slide submitter id: TCGA-28-5211-01C-01-TS1; percent necrosis: 5.0; percent normal cells: 0.0; percent stromal cells: 10.0; percent tumor cells: 85.0; percent tumor nuclei: 80.0; section location: TOP;